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Oxytocin (OT) and vasopressin (VP) are two closely related neuropeptides, widely known for their peripheral
hormonal effects. Specific receptors have also been found in the brain, where their neuromodulatory actions
have meanwhile been described in a large number of regions. Recently, it has become possible to study their
endogenous neuropeptide releasewith the help of OT/VP promoter-driven expression of fluorescent proteins
and light-activated ion channels. In this review, I summarize the neuromodulatory effects of OT and VP in
different brain regions by grouping these into different behavioral systems, highlighting their concerted,
and at times opposite, effects on different aspects of behavior.Introduction
The neuropeptides oxytocin (OT) and vasopressin (VP) are
known to play important roles in the brain. This review examines
the acute neuromodulatory effects of OT and VP, considering
their activity in the context of a restricted number of behavioral
systems. Following a short overview of their molecular proper-
ties, production and release, and characteristics of receptor
binding and intracellular pathways, this review will focus on their
neuromodulatory modes of action. While the neuromodulatory
actions of OT and VP are only beginning to be understood,
they appear to have a widespread distribution of effects that
seems consistent with a diffuse mode of action. Thus, these
neuropeptides have been thought to operate by nontargeted
release from hypothalamic centers reaching receptors by long-
range diffusion. Recently, however, it has become clear that
controlled rapid and local release of OT is possible in different
brain areas, and similar local delivery can be expected for VP.
Thus, it seems possible that their release can be targeted to
selected sets of brain regions, possibly occurring in concert or
in competition. In this review, I aim to provide a framework that
may serve future studies to address the endogenous and tar-
geted modes of actions of these neuropeptides. It considers
their neuromodulatory effects across brain regions in the context
of distinct behavioral systems: olfaction and social interactions,
fear and homeostasis, learning and memory, and sensory and
motor systems.
Oxytocin and Vasopressin: Sequence, Synthesis,
Release, and Delivery
The Sequences of OT and AVP across Evolution
OT and VP are two closely related neuropeptides, both consist-
ing of nine amino acids that only differ at the 3rd and 8th position
(Figure 1). The difference at the 8th position is their most
distinguishing feature, where vasopressin possesses in most
mammals an arginine and OT a leucine. They have appeared
early in evolution with ancestors that can be traced back as far
as the snails and annelids. A VP-like peptide, called [Lys8]cono-
pressin, can be found in cones, leeches, and snails (van Kesteren
et al., 1995). Segmented worms express the homolog peptide
‘‘annetocin’’ and a number of insects express ‘‘inotocin.’’ Inver-
tebrates mostly have only one OT/VP homolog, whereas most142 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.vertebrates have two (Caldwell and Young, 2006). It is thought
that separate genes for VP and OT have arisen by duplication
of a common ancestral gene in jawless fish (cyclostomes) as
long as 500 million years ago. In vertebrates, this duplication
gives rise to two nona-peptide homologs that share five or
more aminoacids with OT/VP (Figure 1). Thus we can find ‘‘isoto-
cin & vasotocin’’ in bony fish; ‘‘mesotocin & vasotocin’’ in lung-
fish, amphibians, reptiles, and birds; and ‘‘OT & phenypressin’’
in marsupials (Darlison and Richter, 1999). Though most mam-
mals are thought to express OT and arginine-vasopressin
(AVP), a new form of OT seems to have arisen in new world
monkeys in which the leucine in position 8 has been replaced
by a proline (Lee et al., 2011). This change alters protein architec-
ture to a much larger extent than the change from mesotocin to
OT, potentially leading to functional changes.
Basic Functions of AVP and OT throughout Evolution
The preservation and even duplication of vasopressin and OT
homologs throughout evolution suggest important and basic
functions for the organism. Indeed, in themollusc Lymnaea stag-
nalis, [Lys8]conopressin, expressed in neuronal and gonadal
cells, influences male copulatory behavior (van Kesteren et al.,
1995). Similarly, in medicinal leeches, [Arg8]conopressin induces
a stereotypical twisting behavior that resembles spontaneous
reproductive behavior by acting on a central pattern generator
of oscillating neurons in reproductive ganglia M5&6 (Wagenaar
et al., 2010). In vocal teleost fish, grunting, an important aspect
of reproductive behavior, is affected by arginine vasotocin in
males and by isotocin in females (Goodson and Bass, 2000). In
some bird species, flock size correlates with mesotocin receptor
distribution in the lateral septum; it can be increased by mesoto-
cin administration and decreased by its antagonist (Goodson
et al., 2009). In most vertebrate peripheral systems, VP and OT
have a role in regulation of body fluids, in certain cases with
opposite roles–e.g., VP is important for water retention and OT
for milk secretion (Valentino et al., 2010).
VP actions have been suggested to be directed toward pro-
tecting homeostasis of the individual (e.g., water retention, blood
pressure, circadian rhythms and temperature regulation,
increased arousal, and memory), and OT actions directed
toward maintenance of the social group and/or species (e.g.,
ovulation, parturition, lactation, sexual behavior, and social
Figure 1. Peptide Sequences of Homologous Vasopressin and Oxytocin Prohormones
Top: outline of basic structure for the OT and VP prohormones.
Lower: aligned individual sequences of VP and OT in different species.
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tempting to see VP as a ‘‘selfish’’ and OT as an ‘‘altruistic’’
peptide (Legros, 2001). Such an opposite yin/yang action was
postulated earlier for central VP andOT function in the rat (Engel-
mann et al., 2000).
Synthesis and Processing
OT and AVP genes in the mouse, rat, and human genomes are
located on the same chromosome separated by a short (3.5–
12 kbp) intergenic region but are in opposite transcriptional
orientations. In the vertebrate brain, OT and AVP are both
synthesized in separate neuronal populations in the hypotha-
lamic paraventricular (PVN) and supraoptic (SON) nuclei as
well as in the ‘‘accessory nuclei’’ (AC) that are situated between
the PVN and SON (Farina Lipari and Valentino, 1993; Farina Li-
pari et al., 1995). In addition to AVP, OT neurons are also found
in the parvocellular neurons of the PVN and suprachiasmatic
nucleus, in the bed nucleus of the stria terminalis (BST), the
medial amygdala, the dorsomedial hypothalamus, and the
locus coeruleus (Buijs, 1978; Caffe´ and van Leeuwen, 1983,
van Leeuwen and Caffe´, 1983), and in rats (but not mice) in the
dorsomedial hypothalamus, vertical diagonal band of Broca,
and olfactory bulb (Caffe´ and van Leeuwen, 1983; Tobin et al.,
2010). It is possible that this is related with species differences
in social behavior.
Expression of AVP and OT in the PVN and SON occurs in
strictly separate neuronal populations, principally as a result of
differential expression at the mRNA level that seems to be regu-
lated by cis-elements (Gainer, 2012). In contrast to humans, the
development of PVN and SON nuclei is late in rodents. Synthesis
of AVP in rats starts between day 16 and 18 in utero and that of
OT few days after birth (Lipari et al., 2001). Both are stored in
secretory granules or vesicles along with their respective carrier
proteins, the neurophysins. Neurophysins for the two peptides
are of similar molecular weight (10 kDa) with a high percentage
of cysteine residues linked by disulfide bridges. Together withAVP/OT, they are synthesized in the cell body as part of
a common precursor protein that contains a glycopeptide at
the amino end, subsequently AVP/OT, and neurophysin at its
carboxy end. Significant processing of this prohormone partly
takes place in the granules that contain the enzymes for post-
translational processing during their transport to the axon
terminal. Thus, for the case of OT, synthesized as nonglycosy-
lated protein, it undergoes endoproteolytic cleavage by the con-
vertase magnolysin to OT-Gly-Lys-Arg (OT-GKR), OT-Gly-Lys
(OT-GK), and OT-Gly (OT-G, also known as OT-X) (Brownstein
et al., 1980; Burbach et al., 2001). The latter is converted by an
alpha-amidating enzyme to the final C-amidated nona-peptide,
a step that is vitamin C dependent (Luck and Jungclas, 1987).
As a result, release at the nerve endings includes the hormones,
the carrier proteins, and residual bits of precursor. Under normal
conditions, the release of the final nona-peptide involves a
calcium-dependent fusion of the granules with the nerve terminal
(Brownstein et al., 1980).
Some mutations (such as P7L AVP) lead to dominant prohor-
mones that are not secreted and accumulate in the endoplas-
matic reticulum forming disulfide-linked oligomers that escape
degradation, gradually aggregate to fibrillar proteins that cause
cell death as in other neurodegenerative diseases (Birk et al.,
2009). Prohormonesmay constitute up to 40%of total OT before
birth and have shown increased ratios in 4- to 6-year-old autistic
children (Green et al., 2001).
Release and Degradation
Classical neurotransmitters are packaged in small synaptic vesi-
cles that are preferentially localized at synapses. Peptides are
stored in large dense-core vesicles (LDCV) which tend to be
distributed in soma, in dendrites, and in axonal varicosities as
well as at nerve endings. Though both can be released by
Ca2+-dependent exocytosis, exocytosis of synaptic vesicles
requires a rise of intracellular [Ca2+] in the proximity of pre-
synaptic Ca2+ channels, whereas peptide release is triggeredNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 143
Table 1. Reports for OT and AVP Fibers in Brain Regions in which
Their Neuromodulatory Effects Have Been Described
Structure OT Fibers VP Fibers
Olfactory bulb Knobloch et al., 2012 Tobin et al., 2010
Olfactory tubercle Knobloch et al., 2012 Tobin et al., 2010
Islands of Calleja Knobloch et al., 2012
Entorhinal cortex Knobloch et al., 2012
MeA Knobloch et al., 2012 Caffe´ et al., 1987
BSTma Knobloch et al., 2012 Caffe´ et al., 1987
VMH Griffin and Flanagan-
Kato, 2011
Kent et al., 2001
CeA Knobloch et al., 2012 Caffe´ et al., 1987
BSTl Knobloch et al., 2012 Caffe´ et al., 1987
NTS Peters et al., 2008 Buijs, 1978;
Sofroniew, 1983
DMN Buijs, 1978;
Sofroniew, 1983,
Buijs, 1978;
Sofroniew, 1983
N. Ambiguus Buijs, 1978;
Sofroniew, 1983,
Buijs, 1978;
Sofroniew, 1983
RVLM Buijs, 1978;
Sofroniew, 1983,
Kc et al., 2010
Parabrachial van Zwieten
et al., 1996.
van Zwieten et al.,
1996
Lateral Septum Sofroniew, 1983 Caffe´ et al., 1987
Hippocampus Buijs, 1978;
Sofroniew, 1983,
Knobloch et al., 2012
Caffe´ et al., 1987
Spinal cord Breton et al., 2008;
Conde´s-Lara et al., 2007
Hallbeck and
Blomqvist, 1999
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changes in intracellular calcium could be brought about by
high-frequency stimulation. Thus, whereas low-frequency stimu-
lation causes a focal increase in Ca2+ at the presynaptic
membrane andwill trigger release of classical neurotransmitters,
a more diffuse rise in intracellular Ca2+ favors peptide release
(Ho¨kfelt, 1991). As a consequence, release of peptide-containing
vesicles is considered to be semi-independent from release of
small synaptic vesicles (Leng and Ludwig, 2008).
The neuropeptide-containing LDCVs can be released from all
parts of a neuron, including the soma and dendrites. Magnocel-
lular neurons of the SON and PVN are densely filled with LDCVs,
and their dendrites, representing 85% of the total volume of
the neuron, therefore contain very large amounts of OT and
AVP. As with presynaptic release, dendritic release is dependent
on the increase in intracellular calcium that results frommobiliza-
tion of intracellular Ca2+ stores (Ludwig and Leng, 2006). Intra-
cellular Ca2+ stores are extensive in somata and dendrites but
often absent from nerve terminals (Sabatier et al., 2007). Some
factors can mobilize these stores without any direct increase in
spike activity. Among these is a-MSH (a-melanocyte stimulating
hormone), originating from preopiomelanocorticoid (POMC)-
producing neurons in the arcuate nucleus and acting onmelano-
cortin 4 (MC4) receptors in SON OT neurons (Ludwig and Leng,
2006). The behavioral actions of a-MSH are strikingly similar to
those of OT, i.e., inhibition of food intake and stimulation of
male sexual behavior, and indeed, it is possible that OT is a
mediator of a-MSH actions (Olson et al., 1991).
Peptide-evoked dendritic release is accompanied by another
phenomenon of interest for neuronal networks: internal [Ca2+]
mobilization can ‘‘prime’’ the secretory vesicles, i.e., make
them available for release in response to subsequent electrical
stimuli (Ludwig and Leng, 2006) This peptide-induced change
in the function of a neuronal compartment produces a recon-
figuration of the local neural network, opening new routes for
communication between neurons. Priming can last for more
than an hour, allowing for long-lasting behavioral effects (Sabat-
ier et al., 2007).
OT and AVP disappear with a half-life of 20 min in cerebro-
spinal fluid (CSF) (Ludwig and Leng, 2006). What is released cen-
trally is degraded within brain tissue by aminopeptidases or
enters the CSF, where it is cleared into the circulation by bulk
flow. The aminopeptidases can cleave OT and AVP into shorter
peptides, some of which have been shown to facilitate avoid-
ance behavior of rats at concentrations 10003 smaller than
AVP, although their efficiency as direct neuromodulators is
much smaller than AVP (Burbach et al., 1983, see below).
Diffusion versus Targeted Release
Though axonal fibers containing OT and AVP have been found in
a large number of brain areas (see Table 1), local release from
dendrites and subsequent diffusion has been proposed to
present an important route of action. To estimate the radius of
effectiveness of OT released from dendrites, Leng and Ludwig
(2008) assumed a basal rate of secretion rate of 0.130 pg/s in
a total extracellular hypothalamic space of 10 ml with a half-life
of 10 s. Their calculations suggest that a concentration of
260 pg/ml can be achieved in 1 min, which seems consistent
with the concentrations of 1000 pg/ml that were measured by144 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.microdialysis from the SON (Neumann et al., 1993). This still
leaves unclear howOT spreads after release, to where it diffuses,
and how quickly and at what concentrations. In the septal nuclei
in the forebrain 4–5 mm away from the SON, OT concentrations
are raised by stimuli to the SON, but to concentrations 10-fold
lower than in the SON itself (Leng and Ludwig, 2008). Though
such concentrations may be effective in eliciting responses by
OT, it is also clear that delay times for obtaining effects will be
considerable. Alternatively, it is possible that OT from the hypo-
thalamus arrives at various brain regions by axonal release from
OT containing fibers specifically targeting the brain areas ex-
pressing the oxytocin receptor (OTR).
We recently explored this issue by infecting rat PVN, AN, and
SON hypothalamic nuclei with a virus construct that assured
fluorescent protein and blue light-sensitive Channelrhodopsin-2
expression under the promoter of OT. This revealed an extensive
network of OT fibers in various areas of the brain, including the
amygdala (Knobloch et al., 2012, see Table 1). It allowed more-
over the induction of local OT release from axonal fibers by
optical activation using blue light targeted to areas of interest
with strong concentration of fibers. In this way, we could show
that blue light exposure of the amygdala decreased fear
responses to levels similar to those produced by external appli-
cation of OT targeted to the amygdala through cannulae (Viviani
et al., 2011). The effects were blocked by preapplication of OTR
Figure 2. Intracellular Pathways for
Oxytocin and Vasopressin
Different intracellular pathways activated by OT or
VP according the specific G proteins that they
activate, leading to activation of TTX-insensitive
Na+ channels or inhibition of K+ channels. Note the
selective recruitment of beta arrestin by Gq11
activation of OT, leading to internalization of the
OTR, but not by Atosiban, which only activates the
Gi/o-coupled OTR.
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and with it, the effect of endogenous OT release. Decreases in
freezing followed as fast as 2 s and on average around 20 s after
onset of blue light (Knobloch et al., 2012). Such a short delay time
makes it unlikely that these effects of endogenous OT in vivo are
due to a diffusion of the nona-peptide from OTergic hypotha-
lamic nuclei.
Taken together, these findings imply an important role of nerve
fiber-carried delivery of OT to targets distant from the hypotha-
lamic OT-ergic nuclei. An interesting model has been proposed
by Landgraf and Neumann (2004) in which they suggest that
axonal release of neuropeptides in limbic area could provide
a local precise spatiotemporal, point-to-point regulation of the
basal level of neuropeptides, in addition to delivery by contin-
uous diffusion. Neuropeptides could communicate with neurons
and modulate different brain structures in a multimodal manner,
both through a ‘‘wired,’’ axonal, fast, and focal manner as well
as in an ‘‘unwired,’’ diffusive, slow, and global fashion. Such a
‘‘coordinated’’ dual mechanism of action based on both a diffuse
release from neurons in the hypothalamus and their collaterals
targeting specific brain structures has recently been proposed
by Ross and Young (2009) to underlie the origin of oxytocin in
the nucleus accumbens.
Receptors for Oxytocin and Vasopressin
Receptors and Intracellular Signaling
VP receptors (VPRs) and OT receptors (OTRs) belong to the G
protein-coupled receptor (GPCR) superfamily, members of
which possess seven putative transmembrane domains (TM1-
TM7), three extracellular (ECL1-3), and three intracellular (ICL1-Neuron 763) loops. These receptors seem to have
arisen very early in evolution, and, similar
to the neuropeptides, it is possible that
different receptors for these compounds
have appeared through gene duplication
and subsequent sequence divergence.
Already in the freshwater snail Lymnaea
stagnalis, which expresses [Lys8]cono-
pressin, two receptors can be activated
that are expressed in mutually exclusive
populations of neurons (van Kesteren
et al., 1995). This has been interpreted
in support of a theory that OT and VP
evolved as ligands for pre-existing recep-
tors. In rodents and human a total of four
receptors have been identified based on
sequences and ligand binding affinities:OTR, V1a-R, V1b-R, and V2-R. Of these, OTR and V1aR are
most abundantly expressed in the brain and will be the focus
of further attention.
Agonist binding to GPCRs leads to receptor activation, phos-
phorylation, and the translocation of beta-arrestin to the receptor
complex, an event that disrupts the receptor/G protein interac-
tion and turns off G protein-dependent signaling. The OTR can
be coupled to different G proteins leading to different functional
effects (Figure 2). OTR coupling to a pertussis-insensitive heter-
otrimeric Gq/11 protein activates the phospholipase Cb pathway
(PLCb), which accumulates phosphoinositide and mobilizes
intracellular Ca2+ mobilization (Wiegand and Gimpl, 2012). This
pathway underlies uterus smooth muscle cell contraction (Alberi
et al., 1997), increases nitric oxide production, which can lead to
cardiomyogenesis (Danalache et al., 2010), and, in neurons, can
inhibit inward rectifying conductances (Gravati et al., 2010). In
neurons, however, OT can also activate inward rectifying
currents through a pertussis-sensitive Gi/o protein, which can
moreover signal antiproliferative effects (Gravati et al., 2010). In
addition, OT can activate adenylate cyclase via a receptor Gs
protein and increase cAMP production, which directly leads,
without PKA activation, to a sodium-dependent TTX-resistant
sustained inward current (Alberi et al., 1997). It is possible that
these various signaling pathways are differentially expressed in
neuronal versus peripheral tissues.
Central V1a receptors are also G protein coupled but can
signal independently of PLCb, PKC, or changes in the intra-
cellular Ca2+ concentration. Electrophysiological research has
shown that AVP and OT can acutely affect neuronal excitability
by opening nonspecific cationic channels or by closing K+, October 4, 2012 ª2012 Elsevier Inc. 145
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inward current, which can be Na+ dependent, tetrodotoxin
insensitive, and voltage gated, and partially blocked by extracel-
lular Ca2+ or Mg2+ such as in the case of AVP in facial motoneu-
rons and OT in vagal motoneurons (Raggenbass et al., 1991). In
addition, in some motoneurons, AVP can suppress a K+ current
(Ogier et al., 2006) that can be barium sensitive (Kolaj and Re-
naud, 1998). The intracellular messengers that activate these
currents are PKC independent but mediated partially by an
AC-cAMP-activated PKA, partially through a yet unknown
pathway (Alberi et al., 1997).
Receptor Modulation and Pharmacology
OTRs can reversibly switch between states of 1–100 nM Kd
affinity for agonists and antagonists depending on the presence
of divalent cations (Mn2+, Mg2+) and specific interactions with
membrane cholesterol. Furthermore, cholesterol also appears
required for efficient OTR expression and can stabilize the OTR
against thermal or proteolytical degradation. Cholesterol-rich
microdomains such as caveolae or lipid rafts can thereby switch
a growth-inhibitory effect, induced by OT in an MDCK epithelial
kidney cell line, into a proliferative response, possibly by recruit-
ing a different signaling cascade (Wiegand and Gimpl, 2012).
In the rat (though not in the mouse, Insel et al., 1993), OTR
expression can be increased by estradiol as well as by with-
drawal of progesterone at constant estradiol levels. This occurs
in a more region-specific manner, possibly as a result of local
progesterone and/or estrogen receptor expression, leading to
increased binding in the ventromedial hypothalamus (VMH),
the principal nucleus of the bed nucleus of stria terminalis
(BST), and medial amygdala, but not in the oval BST and central
amygdala (Windle et al., 2006 and references therein). Studies on
neuromodulation by OT in these areas should therefore be care-
fully controlled for gender and cycle of the animal.
Upon OT activation, OTRs are phosphorylated by G protein-
coupled receptor kinase-2, bind beta-arrestin, and are endocy-
tosed via clathrin-coated vesicles (Smith et al., 2006). After
internalization, they recycle back to the plasma membrane via
the Rab4/Rab5 short recycling pathway (Conti et al., 2009).
This internalization is thought to underlie the rapid desensitiza-
tion that may occur upon OTR activation. Besides the ability of
various G protein isoforms to activate different pathways,
Gi selective ligands generate G protein activation without
beta-arrestin recruitment and OTR internalization (Busnelli
et al., 2012). Interestingly, whereas endogenous OT can activate
OTRs regardless to which G protein they are coupled, specific
agonists and antagonists may exhibit differential affinity to
OTRs, depending on the specific G protein (Gq, Gi, or Go) to
which they are coupled and therefore not cause such internaliza-
tion. Thus, for example, the OTR agonist atosiban does not
promote beta-arrestin1 or beta-arrestin2 recruitment and does
not affect receptor internalization, possibly because of a selec-
tive activation of only those OTR that are coupled to a Gi protein
(Busnelli et al., 2012).
It is possible that these differences also underlie the variability
in desensitization that has been found across different brain
regions. Thus, whereas in the hippocampus, dorsal vagal
complex, and VMH, OT can evoke repeatable excitation with
very little loss of responsiveness, neurons in the central amyg-146 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.dala (CeA) and lateral division of the dorsal BST (BSTld) exhibit
rapid desensitization in spite of high peptide binding (Wilson
et al., 2005). This suggests region expression of different
receptor types or the occurrence of cell-specific receptor
coupling mechanisms and could be of importance in
the development of new drugs targeting specific neuropsychi-
atric diseases (Busnelli et al., 2012).
Though initial agonists and antagonists for VP and OT recep-
tors were mostly peptidergic based, widespread pharmacolog-
ical efforts have resulted in a number of nonpeptidergic com-
pounds (for excellent review, see Manning et al., 2012). It is
important to keep in mind that, though the nomenclature of the
receptors suggests otherwise, significant cross-reactivity of
these receptors exists for their endogenous ligands OT and
AVP. Thus, first of all, AVP binds with a similar affinity to OTRs
as it does to the three AVP receptors. The other way round,
though OT exhibits more specificity for the OTR, it is still able
to bind to VPRs, be it with a 100-fold less affinity (summarized
in Mouillac et al., 1995; Manning et al., 2012). This can
be particularly important before subscribing specific functions
to the endogenous neuropeptides in areas where these different
types of receptors are coexpressed.
Receptor Distributions
In the absence of specific and reliable antibodies for VPRs or
OTRs, expression levels of both neuropeptide receptors have
until now best been addressed by ligand binding studies that
rely on labeled specific agonists or antagonists. In the brain,
these studies have shown the presence of V1a receptors in the
olfactory system, neocortex, basal ganglia, dentate gyrus, BST
and CeA, ventromedial hypothalamus, lateral septum, thalamus,
circumventricular organs, brainstem, and spinal cord (Raggen-
bass, 2008). V1b receptors have only been clearly shown in
a number of these regions most notably the dorsal one-third of
pyramidal cells of the CA2 region, a few cells within the anterior
amygdala, and in the PVN (Young et al., 2006). OTRs in the rat
brain have most prominently been found in the accessory olfac-
tory bulb, anterior olfactory nucleus islands of Calleja, central
and extended amygdala, CA1 of hippocampus, ventral medial
hypothalamus, nucleus accumbens, brainstem, and spinal cord.
Interestingly, a number of these studies have shown that in
brain regions in which AVP V1a and OTRs are coexpressed, their
expression patterns can exhibit remarkable complementarity.
This has been beautifully illustrated for the rat extended amyg-
dala and nucleus accumbens by Veinante and Freund-Mercier
(1997), who found strong expression levels of OTRs in the lateral
part of the CeA, in the shell of nucleus accumbens, and along the
further extended amygdala. AVPRs were expressed in the
medial part of the CeA (CeM), the core of the nucleus accum-
bens, and more medially in adjacent areas of the extended
amygdala. We have meanwhile shown that functional connec-
tions between OTR- and AVPR-expressing regions within the
CeA can underlie the opposite effects of AVP and OT on fear
behavior (Huber et al., 2005, see below). It may be of interest
to examine the presence of such circuitry in other areas exhibit-
ing complementary adjacent expression patterns.
Remarkably few studies have examined the VPR and OTR
levels and distributions in humans. These autoradiographic
studies typically use the same radiolabeled peptides as used in
Neuron
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tors exhibit similar binding characteristics. Furthermore, such
studies in human brain are typically performed at larger time
intervals postmortem as compared to rodent studies though
also in the latter it is not clear how much longer intervals affect
binding results. Results obtained in brains of humans and other
primates for AVP and OT binding have shown some remarkable
species differences for OT for example in the basal nucleus of
Meynert, subiculum, entorhinal cortex, and amygdala. Binding
differences for AVP were less marked though binding was
remarkably limited (Loup et al., 1991). A promising field of
discovery in this context is the development of reliable
radioligands for in vivo PET neuroimaging for OTR or V1aR.
Only recently some new promising products have emerged
using 18F or 125I and 11C as isotopes, but the use of these
compounds is still limited to in vitro studies. The current search
is for radioactive ligands that can easily penetrate the blood brain
barrier, thereby allowing PET scan studies of OT and AVP recep-
tors levels in living human subjects (Smith et al., 2012).
Differences across Species and Genders and within
Lines
Studies on distribution of V1a and OTRs in the brain have shown
interesting differences in expression levels between individuals
of the same or closely related species and a correlation with
striking differences in behavior. The most well-known example
of this are the prairie voles in which higher expression levels of
OTRs in the female nucleus accumbens and V1aRs in the male
lateral septum and ventral pallidum causatively correlate with
the formation of stable pair bonds between male and female
voles after coupling behavior whereas lower levels lead to less
monogamous behaviors (Hammock and Young, 2005; Ross
et al., 2009). Except for the lateral septum, surprisingly little elec-
trophysiological research seems to have examined whether OT
and AVP exert acute neuromodulatory effects in these regions.
The precise mechanism underlying the formation of stable pair
bonds remains a field of exploration. It is also possible that these
differences in OT/VP signaling create a permissive environment
for learning to occur, rather than being directly involved in the
induction of the pair bonding (for review see Donaldson and
Young, 2008).
A number of rat lines also exhibit a correlation between OT and
AVP receptor expression levels and specific types of behavior.
Notorious examples are the differences identified by Cham-
pagne and Meaney (2001) between high- and low-licking and
grooming mother rats characterized by more maternal care
and lower anxiety and fear levels. These can be associated
with higher levels of OT in the medial preoptic area, paraventric-
ular nucleus, lateral septum, amygdala, and BST, the latter two
regions well known for their role in anxiety and fear behavior. A
similar association was noticed in mice, bred for different levels
of nursing and licking/grooming, between levels of OT and V1a
receptors in the lateral septum and frequencies in, respectively,
nursing and licking/grooming (Curley et al., 2012). Similarly, LAB/
HAB mice and rats show interesting distinctions in AVP and OT
signaling that can be related with a large spectrum of different
behaviors (Veenema and Neumann, 2007). Such animal models
may serve important roles to study similar variations within the
human population.Neuromodulatory Effects of Vasopressin and Oxytocin
The distinct and potentially opposite roles of OT and AVP in the
periphery suggest a certain complementary development in the
evolution of their functions. In the brain, expression of OT and
AVP takes place in nonoverlapping areas, and though at times
juxtaposed, remains distinctly separated in different sets of
neurons. Similarly their receptors are typically expressed in dif-
ferent regions of the brain, and, where these regions are close
neighbors, the expression of their receptors occurs in strictly
separate sets of neurons. The question therefore arises of
whether it is possible to distinguish across these different brain
regions contrasting and complementary roles of the signaling
by these neuropeptide receptors. In this section, I will go through
the different parts of the brain in which the expression and acti-
vation of their receptors have been found and evaluate their
functions in light of potential complementary roles.
A large number of electrophysiological studies have already
been performed on acute neuromodulatory effects of both
peptides in various brain areas. At first glance the effects seem
diverse and dispersed in many regions, without a clear organiza-
tional pattern. Nevertheless, it may be possible to group some of
these regions by considering them as part of neuronal circuits
that underlie similar functions. For example, subsets of circuits
comprise core networks that integrate the behavioral, physiolog-
ical, and motivational processes related to specific neural
‘‘tasks.’’ Thus, we can identify a core network for social behavior
within the limbic system, another network for stress and anxiety,
for learning and memory, or more simply sensory and motor
tasks (see also Goodson and Kabelik, 2009). Following this
approach, in the following parts the hitherto identified neuromo-
dulatory effects of AVP and OT have been tentatively grouped
within such networks. Of course, these cannot be strictly segre-
gated, and it should be kept in mind that neurons can participate
within several networks; for example, neurons acting with the
network underlying social behavior can also contribute to pro-
cessing within the networks involved in stress and anxiety.
Following an early definition proposed by Kupfermann (1979),
neuromodulation, unlike conventional neurotransmission, does
not simply excite or inhibit an electrically excitable cell, but is
rather involved in altering the effects of other events occurring
at the cell. Most reports on the neuromodulatory effects of
AVP and OT, however, have up to now only studied effects of
external application of these neuropeptides, often resulting in
robust changes in spontaneous neuronal activity. However
such ‘‘spontaneous’’ activity is typically generated under precise
given circumstances in vitro (e.g., changes in external concen-
trations of Ca2+ or K+) that in vivo may depend on conventional
neurotransmission. In strictest sense, these studies can there-
fore not distinguish between a role of OT and VP as conventional
neurotransmitters or as neuromodulators. In this context it is
important to keep in mind that neuropeptides typically are
thought to be coreleased with other classical neurotransmitters
such as glutamate or GABA only at higher frequencies of stimu-
lation (Ho¨kfelt, 1991). Consistently, our findings with the blue
light-induced stimulation of endogenous release of oxytocin
suggest corelease with glutamate (Knobloch et al., 2012) and
a similar scenario may apply for vasopressin. The development
of optogenetic methods to specifically stimulate OT and AVPNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 147
Figure 3. Neuromodulation by OT and AVP of Systems Involved in Social Signaling
OTR-expressing (in red) and AVPR-expressing (in green) regions in the brain and their connections involved in transmitting olfactory stimuli and pheromones to
brain regions important for signaling social relevance. Shaded panels indicate levels at which insets were taken that are shown below.
(A) Olfactory bulb showingMCswith cell body excited by AVP and dendrites that excite (arrows) and also in return are inhibited by GC dendrites (squares) that are
themselves inhibited by OT.
(B) BSTma-expressing OTRs on cell bodies excited by OT.
(C) Posterodorsal part of medial amygdala (MePD)-expressing OTRs on cell bodies excited by OT (MePV = posteroventral part of medial amygdala).
(D) VMH-expressing OTRs on dendrites that are excited by OT.
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possibly even crucial, tool to dissect the precise neuromodula-
tory roles of these neuropeptides in situ.
Effects in the Olfactory System and on Social Behavior
Olfactory Regions
AVP and/or OTRs are expressed in different regions of the main
and accessory olfactory systems. In the main olfactory epithe-
lium, mRNA for both V1a and V1b receptors has been detected
(Levasseur et al., 2004). Furthermore, in an immortalized cell
line displaying the features of immature, migrating olfactory
neurons (GN11), activation of OTRs led to the accumulation of
inositol phosphates and to the inhibition of an inwardly rectifying
potassium currents (Gravati et al., 2010). No studies seem to
have addressed a role in the pheromone-sensitive epithelium
of the vomeronasal organ.
At the next level, V1a&bRs as well as OTRs are expressed in
both the main (MOB) and accessory olfactory bulb (AOB) (Tobin
et al., 2010; Vaccari et al., 1998). Although the MOB and AOB
receive distinct inputs from, respectively, the olfactory epithe-
lium and vomeronasal organ, their anatomical organizations
appear very similar. In both bulbs, mitral cells (MCs) constitute148 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.the main relay neurons. Dendrites of mitral cells make excitatory
contact with dendrites of local granule cells (GCs) and in return
receive inhibitory dendritic inputs from GCs (Figure 3A). This
reciprocal circuit is thought to play a role in the refinement of
olfactory and pheromonal signaling. In both mitral and granule
cell layers OTR mRNA and OT-immunoreactive fibers have
been found (Knobloch et al., 2012; Vaccari et al., 1998; Yoshi-
mura et al., 1993). Neuromodulation by both OT and AVP
increased excitability of mitral cells via a V1a receptor (Osako
et al., 2000, 2001). Furthermore, the AVP effects could be endog-
enously triggered by AVP-producing cells that are locally present
in the MOB (Tobin et al., 2010). Specific OTR activation caused
a decrease of the inhibitory input from GC on MC neurons
through a presynaptic mechanism, an effect that seemed impor-
tant for the induction of maternal behavior (Yu et al., 1996; Osako
et al., 2001). It thus appears that in the MOB and AOB, AVP and
OT may reinforce each other’s actions, AVP by increasing exci-
tation, OT by decreasing inhibition. It has been proposed that,
through these concerted actions, both AVP and OT applications
to the olfactory bulb also lengthen the retention interval for short-
term social odor recognition in male rats (Dluzen et al., 1998). Of
interest in this context, OT can lower the threshold for LTP
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granule cells in the AOB (Fang et al., 2008).
Medial Amygdala and Bed Nucleus of Stria Terminalis
TheMOB sends projections to the anterior olfactory nucleus, the
piriform cortex, some subdivisions of the cortical amygdala, and
the medial amygdala. Most projections to the MeA, however,
originate from the AOB (Switzer and DeOlmos, 1985; Swanson
and Petrovich, 1998). The AOB also projects to the posterior
medial subdivision of the cortical amygdala (COApm) and to
the bed nucleus of the stria terminalis (BST) with which the
MeA is reciprocally connected (Alheid and Heimer, 1988). This
is the major pathway for processing pheromonal cues and
important for social interactions (Brennan and Zufall, 2006;
Swanson and Petrovich, 1998), and the MeA is for that reason
also called the ‘‘vomeronasal amygdala.’’ In the MeA of male
rats, mRNA for V1aR, V1bR, and OTRs is present and binding
of specific OTR antagonists has been demonstrated (Arakawa
et al., 2010; Veinante and Freund-Mercier, 1997). Male OT
knockout mice lack short-term conspecific social recognition,
which can be rescued by local microinjections in MeA of OT prior
to the first exposure (Ferguson et al., 2001) and mimicked by
antisense oligonucleotides targeting the OTR (Choleris et al.,
2007). Interestingly, an OT antagonist injected in the MeA
blocked approach behavior to odors of healthy conspecifics,
whereas a V1a antagonist blocked avoidance of odor to sick
conspecifics, suggesting nonoverlapping, but contrasting, roles
for these peptides in this region (Arakawa et al., 2010). In theMeA
and the BST, local AVP-producing neurons have been found
(Caffe´ and van Leeuwen, 1983; van Leeuwen and Caffe´, 1983)
and in the MeA OTergic fibers that originate from the PVN and
SON (Knobloch et al., 2012).
Although these findings point to important functions in social
behavior for AVP and OT in the MeA and BST, only a few studies
seem to have examined neuromodulatory effects in this area.
Terenzi and Ingram (2005) showed strong, excitatory effects of
OT in the posterodorsal division of the MeA (MePD, Figure 3C),
a region with a high density of OT binding sites (Veinante and
Freund-Mercier, 1997). These responses were larger and longer
lasting, more sensitive and less desensitizing to repeated appli-
cations than in the CeA (see below), and no inhibitory responses
were found. Ingram’s group found similar sensitive nondesensi-
tizing effects of OT in the medial anterior subdivision of the BST
(BSTma, Figure 3B, Wilson et al., 2005), a region homologous to
the MeA that, interestingly, could be potentiated by oestradiol or
progesterone (Wakerley et al., 1998).
Ventromedial Hypothalamus
The OT-sensitive BSTma and MePD are typically activated by
sensory stimuli that evoke reproductive behavior. The MePD
projects to three interconnected hypothalamic nuclei implicated
in reproductive behaviors: the medial preoptic nucleus, the
ventral premammillary nucleus, and the ventrolateral part of
the ventromedial hypothalamus (VMHvl, Figure 3D, Choi et al.,
2005). Activation of these nuclei in females can rapidly induce
lordosis (Hennessey et al., 1990). Both OT-containing fibers
and OTRs are found in the VMHvl and OT application causes
excitation of VMHvl neurons (Kow et al., 1991). Similar to the
neuromodulatory OT effects in the BST, these effects were
strongly potentiated by treatment with estrogen, though not byprogesterone. This is in keeping with the estrogen-induced
increases of number of OTRs in the VMHvl, compared to proges-
terone, which rather seems to cause dendritic extensions and
a shifting of OTRs to more distal dendritic locations in the VMHvl
(Griffin and Flanagan-Cato, 2011). AVPergic fibers have also
been found in the VMH (Kent et al., 2001), but a neuromodulatory
has not (yet) been reported.
Taken together, it appears that in circuits involved in pro-
cessing social olfactory cues, OT and AVP play important neu-
romodulatory roles by increasing neuronal activity thereby
affecting reproductive behavior, including social recognition,
induction of lordosis, andmaternal behavior. Though on different
components of the pathway, both seem to complement and
reinforce each other’s effects (contrary to a number of strikingly
opposite effects they can exert in other systems, see below). In
view of the sensitivity to estrogen and progesterone, significant
divergence may, however, exist between genders.
Opposite Effects on Alert and Homeostasis
Central Amygdala and BST
OT and AVP show strikingly opposite effects on a number
of behavioral aspects of anxiety and fear. Evidence for this
was found first in rats, where administration of OT revealed
anxiolytic and antistress effects. AVP, on the other hand, in-
creased anxiety-like behavior and visceral responses associated
with fear including bradycardia and increases in colonic motility
(Bueno et al., 1992, Koolhaas et al., 1998, Roozendaal et al.,
1993).
An important area considered to determine these opposite
effects was the central amygdala (CeA), a nucleus in the brain
that plays an important role as alert center for potentially
dangerous stimuli in the environment, and whose activation
evokes typical fear responses. Local CeA injections of AVP
increased typical fear responses as reflected by a decrease in
heart rate and in behavioral motility, and OT increased heart
rate and behavioral motility (Roozendaal et al., 1993). The medial
part of the CeA (CeM) is the main output of the CeA to the hypo-
thalamus and brainstem areas whose activation underlies the
physiological expression of the fear response. It receives projec-
tions from the lateral and basolateral amygdala (BLA), where
synaptic plasticity has been shown to underlie fear learning (Viv-
iani and Stoop, 2008). The CeA shares many similarities with the
lateral part of the BST (BSTl); both structures receive from and
project to brain regions that mediate fear-associated behaviors.
This similarity in connectivity has led to the notion that the CeA
and BSTl are part of a basal forebrain continuum that has been
termed the ‘‘extended amygdala’’ (Alheid and Heimer, 1988).
Within this structure, it has been proposed that the CeA fulfills
an important role in acute (phasic) fear behavior and the BSTl
in sustained fear (i.e., anxiety; Walker et al., 2009).
Interestingly, both the CeA and the BSTl show a clear comple-
mentary expression of OT and V1aRs (Veinante and Freund-Mer-
cier, 1997) with V1aRs highly expressed in the CeM and OTRs in
the adjacent, lateral part of the CeA (CeL). This complementarity
can be found throughout the extended amygdala, persisting up
to the BSTl (Veinante and Freund-Mercier, 1997; Figure 4). These
findings, in combination with the GABAergic projections from the
CeL to the CeM subdivision (Jolkkonen and Pitka¨nen, 1998),Neuron 76, October 4, 2012 ª2012 Elsevier Inc. 149
Figure 4. Neuromodulation by OT and AVP in Regions for Alert and Homeostasis
OTR-expressing (in red) and AVPR-expressing (in green) regions in the brain and their connections involved in fear and anxiety. Shaded panels indicate levels at
which insets were taken that are shown below.
(A) BST with laterodorsal (BSTld) part expressing OTRs on cell bodies excited by OT and posterolateral (BSTlp) part expressing AVPRs. An inhibitory connection
between both areas has been suggested similar to the homologous CeA.
(B) CeA with lateral/capsular part expressing OTRs directly excited by OT and medial part expressing AVPRs directly excited by AVP and indirectly inhibited by
OT-activated inhibitory projections from CeL.
(C) Dorsal part of lateral parabrachial nucleus (LPBD) expressing AVPRs with neurons receiving excitatory input from neurons lateral to the superior cerebellar
peduncle (scp) that is presynaptically inhibited by AVP (MPB = medial parabrachial nucleus).
(D) DMN neurons directly excited by OT and indirectly inhibited through presynaptic inhibitory effects of AVP on synapses in the NTS.
(E) RVLM neurons directly excited by AVP and NA neurons indirectly inhibited by inhibitory neurons excited by AVP.
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effects of OT and AVP in the CeA (see below).
The first studies that showed neuromodulatory effects of OT
and AVP on cellular activity in the CeA were published by Con-
de´s-Lara et al. (1994) and Lu et al. (1997). They laid the basis
for a series of investigations in our laboratory concerning the
precise role of OT and AVP in the different parts of the CeA
(Huber et al., 2005). Starting with extracellular single-unit record-
ings, we were able to identify two major populations of neurons,
one excited by AVP but inhibited by OT, the other only excited by
OT and unresponsive to AVP. The effects of AVP were mediated
by the V1aR, whereas those of OT were blocked by traditional
OTR antagonists and, contrary to OT effects in the MeA (Terenzi
and Ingram, 2005), rapidly desensitizing. The inhibitory effects of
OT could be reduced by blocking GABAergic transmission,
which suggested that they might be indirectly mediated by an
increased release of GABA. The excitatory effects, on the other
hand, were unaffected by GABA and appeared to be directly
mediated, similarly to the findings of Terenzi and Ingram (2005)150 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.in the CeA. To investigate the morphology and projections of
these excited neurons, we combined sharp electrode recordings
with intracellular labeling of individual neurons. Our observations
revealed that OT-excited neurons were localized in the CeL,
whereas AVP-excited cells were found in the CeM. Subsequent
tracing studies showed that the axon collaterals of the OT-
excited cells projected far into the CeM, and immunohisto-
chemical staining showed that they were GABAergic. Further
whole-cell patch-clamp recordings indeed showed that the
inhibitory effects of OT were related with a massive increase of
inhibitory GABAergic currents, induced by the activation of the
CeL neurons (Huber et al., 2005). The above set of results led
us to the development of a model in which the opposing behav-
ioral effects of AVP and OT are caused by a selective activation
of two distinct populations: GABAergic neurons in the CeL are
activated by OT and project to the CeM, where they exert inhib-
itory effects on neurons that are directly activated by AVP
receptors (Figure 4B). OTergic modulation of the inhibitory
projection from the CeL onto the CeM can therefore control
Neuron
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(Huber et al., 2005). Of potential interest in this context, it
deserves mentioning that both the ventral CA1 and subiculum
send direct projections to the CeA, especially its capsular part
(Cenquizca and Swanson, 2007), which may have the potential
to mediate the ventral hippocampal contribution to fear learning
(see below).
With the aforementioned homology between the CeA and
the BSTl and their high levels of adjacent, nonoverlapping OTR
and V1aR binding sites (Veinante and Freund-Mercier, 1997;
Figure 4A), the question arises whether opposite effects of OT/
AVP can also be found in the BSTl? Though no effects of V1aR
activation seem to have been reported yet, strong excitatory
effects of OT have been reported (Wilson et al., 2005). Similar
to the desensitization differences between the CeA and MeA
(Terenzi and Ingram, 2005; see above), OT effects in the BSTl
showed faster desensitization compared to the BSTma. Both
the CeA and BSTl are reciprocally connected to brainstem
centers, particularly the dorsal vagal complex and parabrachial
nucleus (Gray and Magnuson, 1987; Moga et al., 1989), and it
is possible that OT action in these nuclei is involved in modu-
lating autonomic functions.
Dorsal Vagal Complex, Nucleus Ambiguus, and Rostral
Ventrolateral Medulla
The nucleus of the solitary tract (NTS) is the major visceral
sensory relay nucleus in the brainstem and receives signals
from arterial baroreceptors, chemoreceptors, cardiopulmonary
receptors, and other visceral receptors in an ‘‘organ-topic’’
manner through inputs from the solitary tract (ST). It is heavily
innervated by the CeA and projects back to among others the
CeL, as well as to the dorsal motor nucleus of the vagus (DMN)
and the rostral ventrolateral medulla (RVLM, Figures 4D and
4E). Through the DMN and RVLM it maintains a reflex arc for
the regulation of both cardiovascular (arterial baroreflex) and
gastrointestinal responses. The DMN forms with the NTS the
so-called dorsal vagal complex (DVC) and is probably the sole
source of parasympathetic control of the upper gastrointestinal
tract. It mediates the effects of the amygdala on the gastrointes-
tinal system and on the cardiovascular system by decreasing
heart rate (Loewy and Spyer, 1990). On the other hand, neurons
in the RVLM are the major source of descending input to the
sympathetic vasomotor neurons in the spinal cord, which play
a major role in increasing tonic and reflex control of blood pres-
sure (Saha et al., 2005).
AVP has been shown to decrease excitatory glutamatergic
inputs from the ST to some neurons in the NTS by selectively
reducing the probability of release and to others by blocking
axonal conduction (Bailey et al., 2006). Contrariwise, OT has
been found to excite preganglionic DMN neurons by generating
a sustained inward current (Charpak et al., 1984). This was
mediated by two pathways, involving a Gq/11 protein that acti-
vated PLC and intracellular Ca stores and a Gs-dependent
protein that activates cAMP (Alberi et al., 1997). Besides in the
DMN, cardiac parasympathetic neurons are also located in
the nucleus ambiguus (Amb). Whole-cell recordings of synaptic
activity in identified cardiac parasympathetic ambiguus neurons
has revealed that AVP can enhance inhibitory input to these
neurons by increasing the frequency and amplitude of spon-taneous GABAergic inhibitory postsynaptic currents (Wang
et al., 2002). Amplitudes of miniature inhibitory synaptic events
were not affected, indicating that AVP probably acted at the
somatodendritic membrane of presynaptic GABAergic neurons.
This effect was suppressed by a selective AVP V1a receptor
antagonist and could not be mimicked by an AVP V2 receptor
agonist. By decreasing the parasympathetic outflow to the
heart, this mechanism could contribute to the AVP-induced
stimulation of heart rate and inhibition of reflex bradycardia.
Consistent with this, injection of AVP in the RVLM, adjacent to
the Amb, increased heart rate and blood pressure, an effect
that seemed to be mediated by V1a receptors. The RVLM
receives AVPergic projections from the PVN and stimulation of
the PVN evoked similar sympathetic responses that could be
blocked by V1a receptor antagonists. However, no electrophys-
iological recordings seem to have been performed yet to show
directly such acute neuromodulatory effects of AVP in the
RVLM (Kc et al., 2010).
Parabrachial Nucleus
The parabrachial nucleus (PB), located in the pons, reciprocally
connects with the CeA and receives input from the NTS. It is
considered to be a secondary relay center for nociceptive trans-
mission, gustation, cardiovascular, and respiratory regulation
(van Zwieten et al., 1996). Similar to the NTS, it receives sensory
and visceral information, among which glutamatergic inputs
from baroreceptor afferents (Saleh et al., 1997). It contains two
neuronal systems that oppositely affect cardiovascular function,
one eliciting pressor-tachycardic responses, the other leading
to depressor-bradycardic responses (Chamberlin and Saper,
1992).
Both AVP and OT immunoreactive fibers are present in the rat
lateral PB, but AVP fibers predominantly (van Zwieten et al.,
1996). This same group found that AVP, via V1a receptors,
decreased to 70% excitatory postsynaptic currents (EPSC)
evoked by stimulation of glutamatergic inputs from the superior
cerebellar peduncle. AVP did not affect postsynaptic responses
to direct glutamate application, suggesting a presynaptic site
of action (Figure 4C). Interestingly, aminopeptidase inhibition
caused a reduction in the EPSC that could be blocked by a V1
receptor antagonist, suggesting an effect (and a degradation)
of endogenous AVP.
Similar to the NTS, by reducing excitatory neurotransmission
of parasympathetic output, AVP may thus increase heart rate
and blood pressure. At the same time, the lateral PB also sends
dense projections to the CeL, which are specifically involved in
processing and relaying aversive sensory information and are
necessary for taste aversion learning (Fanselow and Dong,
2010) and AVP may also affect this pathway. Though OT-immu-
noreactive fibers have also been identified in the PB, neither
OTRs (Tribollet et al., 1989) nor OTR mRNA have been localized
(Chen and Pittman, 1999), and there seem to be no reports on
neuromodulatory effects by OT in the PB.
Opposite Effects of OT and AVP on Alert and
Homeostasis
Taking the above elements together in the context of alert and
homeostasis, an interesting concert of opposite effects for OT
and AVP seems to emerge: AVP increases alert for external
stimuli by activating the CeM and, at the same time, increasesNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 151
Figure 5. Neuromodulation by OT and AVP of Systems Involved in Memory and Learning, as well as of Sensory and Motor Systems
OTR-expressing (in red) and AVPR-expressing (in green) regions in the brain and their connections involved in memory and learning (left side) and sensory and
motor systems (right side). Shaded panels indicate levels at which insets were taken that are shown below.
(A) Lateral septal region (LS) with dorsal part (LSD) expressing OTRs on cell bodies excited by OT and ventral part (LSV) expressing AVPRs on inhibitory neurons
inhibiting projections neurons.
(B) Hippocampal region (Hipp) with dentate gyrus (DG)- and CA3-expressing AVPRs and CA1- and subiculum-expressing OTRs on inhibitory interneurons in the
pyramidal layer that inhibit pyramidal neurons.
(C) Facial nucleus (VII)-expressing AVPRs on neurons excited by AVP.
(D) Hypoglossal nucleus (XII)-expressing AVPRs on neurons that are directly excited by AVP, indirectly excited by AVP activation of excitatory glutamatergic
premotor neurons, and indirectly inhibited by OT activation of inhibitory interneurons releasing GABA or glycine (Wrobel et al., 2010).
(E) Spinal cord expressing OTRs on dorsal side that presynaptically excite local inhibitory neurons and on ventral side AVP-excited neurons which are inhibited by
projections from OT-excited neurons, suggested to originate from the dorsal part.
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decreases parasympathetic output by inhibiting input to the
DVC and output from the Amb and PB. In contrast, OT decreases
alert by inhibiting output from the CeM and increases parasym-
pathetic flow by exciting output from the DMN. Together, it is
possible that the concerted actions of OT and AVP play an
important role for controlling homeostasis when an animal is
alerted to external challenges.
Opposite Effects on Memory and Learning
Hippocampus and Subiculum
Receptors for OT and AVP show a clear segregated expression
in the ventral hippocampal region (Figure 5). OTRs are found in
the CA1 region and the subiculum, AVPRs in the dentate gyrus
and CA3 region (Zaninetti and Raggenbass, 2000). Initial studies
in rodents seemed to indicate that AVP could increase memory,
antagonize amnesia, and facilitate memory consolidation (de
Wied et al., 1993). A cellular basis for these effects arose with
the discovery that inhibitory neurons in the CA1 area could be
directly excited by AVP and OT, whereas pyramidal neurons
were inhibited (Mu¨hlethaler et al., 1982, 1984; Tiberiis et al.,
1983). OT and its structural analogs were more potent than
AVP, suggesting an activation of OTRs (Mu¨hlethaler et al.,
1984). In-depth analysis by Zaninetti and Raggenbass (2000)152 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.indeed confirmed that the inhibition of pyramidal neurons was
caused by an excitatory action of OT on GABAergic interneurons
that were mostly located within the stratum pyramidale
(Figure 5B). The excitatory effects of OT were restricted to the
soma and/or dendrites of these interneurons, and, although
OTRs have been found in hippocampal synaptosomal
membranes (Audigier and Barberis, 1985), no evidence was
found for direct excitatory effects on the axon terminals. This
hippocampal action of OT appeared species dependent. For
example, in the guinea pig, the hippocampus shows no OT
binding sites and CA1 hippocampal interneurons are unaffected
by OT (Raggenbass et al., 1989).
Whereas this neuromodulation by OT was acute and revers-
ible within minutes, AVP effects in the hippocampus have in
many cases been shown to last much longer. Typically, they
occur at concentrations of only a few pM (compared to
100 nM for acute effects) and cause, without directly affecting
neuronal excitability, a potentiation of synaptic transmission
that emerges over several minutes and outlasts the AVP applica-
tion for up to an hour. These effects can also be produced by
shorter AVP fragments (e.g., AVP4-8), but they are insensitive
to V1a receptor blockade (Du et al., 1998). Thus, it remains
unclear which or whether specific receptors are activated and
which intracellular pathways are involved. Similarly, long-term
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synapse. These effects depended on CREB-phosphorylation
through a MAP kinase pathway and were also not mediated
through an acute neuromodulatory mechanism (Tomizawa
et al., 2003). It is possible that neuropeptides play a trophic
role in the hippocampus, as also proposed in the spinal cord
(see below). For example, repeated OT injections in the dentate
gyrus can increase neurogenesis (Leuner et al., 2012). Similarly,
Iwasaki et al. (1991) noted a neurotrophic action of AVP, but not
OT, in explanted spinal cord cultures. Tribollet et al. (1991; 1994)
demonstrated a transient increase of AVP binding in motoneu-
rons in neonatal spinal cord and similarly 14 days after axotomy,
both suggestive of a trophic activity.
The above findings seemed promising for treating patients
affected by memory problems and have indeed been followed
by clinical studies. Whereas some studies showed an improve-
ment in memory mediated by AVP, others reported mixed find-
ings or were unable to show positive results (reviewed in Viviani
and Stoop, 2008). Though OT-containing axons originating from
the PVN are present in the hippocampus (Buijs, 1978; Knobloch
et al., 2012), the precise function of hippocampal OT signaling
remains as of yet unknown. It is possible that OT may affect
network oscillations or synchronization or affect synaptic plas-
ticity (Freund and Buzsa´ki, 1996). Interestingly, following gener-
alized seizures, a selective activation of OT-expressing neurons
(and a long-lasting upregulation of OT mRNA) occurs in the PVN
(Sun et al., 1996). This raises the intriguing possibility that OT,
by enhancing inhibitory transmission in the hippocampus, may
act as an endogenous anticonvulsant (Zaninetti and Raggen-
bass, 2000).
Lateral Septum
The septum and hippocampus are heavily interconnected, sug-
gesting these two structures share similar functions. The hippo-
campus sends amassive, glutamatergic innervation to the lateral
septum (LS), with progressively more ventral parts of the hippo-
campus innervating progressively larger and more ventral LS
regions (Risold and Swanson, 1997). Thus, the ventral hippo-
campus innervates a much greater volume of the LS than does
the dorsal hippocampus. The caudal part of the LS receives
projections from the CA3, whereas the CA1 hippocampus and
subiculum project to the rostral LS (Trent and Menard, 2010).
The ventral LS is rich V1a receptors (Freund-Mercier et al.,
1988), as well as OTRs, which can also be found in the dorsal
LS (Curley et al., 2012). The LS is densely innervated by AVPergic
axons, originating mostly from AVPergic neurons in the BST and
the amygdala (Caffe´ et al., 1987) and by OTergic axons origi-
nating from neurons in the PVN and SON (Knobloch et al.,
2012). A number of studies have indicated that AVP and OT
signaling in the LS is important for social recognition and related
social behaviors including maternal care (Bielsky and Young,
2004; Bielsky et al., 2005; Caffe´ et al., 1987; Veenema et al.,
2010, Curley et al., 2012). In rats, septal administration of AVP
increases short-term social recognition memory (Dantzer et al.,
1988) and rescues social memory of Brattleboro rats that natu-
rally lack AVP (Engelmann and Landgraf, 1994). Similarly, in
mice, overexpression of V1a receptors in the LS increases social
recognitionmemory (Bielsky et al., 2005), and viral re-expression
of V1a receptors in the LS in V1aR KO mice can completelyrescue deficits in short-term social recognition (Bielsky et al.,
2005). Furthermore, levels of OTR expression in the LS have
been correlated with frequency of nursing by lactating females
(Curley et al., 2012) These studies suggest the LS may play an
important role for the social and affective bonds that AVP and
OT modulation has been found to affect in humans (Kosfeld
et al., 2005; Storm and Tecott, 2005).
In spite of these important behavioral implications, studies on
the neuromodulatory actions of AVP and OT in the septum at the
cellular level are relatively sparse. AVP applied by iontophoresis
(Joe¨ls and Urban, 1982) or by bath perfusion on in vitro slices
(Raggenbass et al., 1987) showed an excitation in 30%–40%
of septal neurons. Effects were concentration dependent and
were mediated by a V1a-R that was also somewhat sensitive
to OT (Raggenbass et al., 1987). Further experiments revealed
a more complex picture, in which AVP can directly excite a
subpopulation of GABAergic inhibitory neurons and, through
these, indirectly inhibit a large population of inhibitory projection
neurons (see Figure 5A). All effects were mediated by V1aR,
without involvement of the V1bR (Allaman-Exertier et al., 2007).
As a result AVP would lead to a disinhibition of target structures
among which are the hypothalamic nuclei involved in behavioral
tasks (Risold and Swanson, 1997) important for social recogni-
tion. The direct excitatory effects of AVP on GABAergic neurons
may possibly also modulate the theta rhythm that is known to
originate in the septal area and propagate to the hippocampus
(Urban, 1998). No effects of OT in the dorsal LS seem to have
been reported. In addition to these acute neuromodulatory
effects, long-lasting facilitating effects of AVP on evoked post-
synaptic potentials that persist well beyond the period of AVP
administration have been reported. As in the hippocampus,
these effects of AVP appeared at low concentrations (1 pM).
This long-lasting effect could not be blocked by a V1 receptor
antagonist (Van den Hooff and Urban, 1990).
Taken together, these findings indicate that in the hippo-
campus and LS, AVP and OT can exert reversible neuromodula-
tory effects as well as long-lasting potentiating effects on
synaptic transmission. It is possible that neuromodulation of
oscillatory rhythms may in addition affect synaptic plasticity
and memory processing, such as required for social memory
and cognition. In view of the adjacent expressions of V1aR and
OTR in both these reciprocally connected regions, it remains to
be explored to what extent OT and AVP can complement each
other’s functions.
Opposite Effects on Sensory and Motor Regulation
Spinal Cord
Both OT and V1aRs have been found in the spinal cord, with
a striking segregation of OTRs in the dorsal and AVPRs in the
ventral part (Figure 5E). This is matched by OT projections
from the hypothalamus terminating in lamina I-II (Breton et al.,
2008) and AVP projections to the ventral parts (Hallbeck and
Blomqvist, 1999). The specific OT-agonist [Thr4Gly7] OT
(TGOT) activates here a subpopulation of lamina II glutamatergic
interneurons that project onto GABAergic interneurons. OT
thereby elevates inhibition of the nociceptive afferent messages
that originate from C and Ad primary afferents. These findings
could explain the analgesic effects that have been reported forNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 153
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Expression of V1aRs is particularly high in the spinal cord of
young rats, declining in older individuals (Liu et al., 2003). AVP
excites motoneurons via a postsynaptic mechanism involving
suppression of a resting K+ conductance and activation of
a cationic conductance in laminae VIII and IX of the lumbar spinal
cord and in the sexually dimorphic pudendal motoneurons in
segments L5 and L6, which play a critical role in sexual and elim-
inative functions (Ogier et al., 2006). AVP can also excite glyci-
nergic interneurons that innervate these motoneurons, thereby
indirectly increasing inhibition (Kolaj and Renaud, 1998; Oz
et al., 2001). However, this effect was also observed with the
specific OT agonist TGOT, and it is therefore possible that this
was instead mediated by OTRs in layers I and II and excitation
of inhibitory interneurons that also send collaterals to these
motoneurons (Liu et al., 2003; see Figure 5B). This circuit could
thus orchestrate the opposite, inhibition by OT of sensory input
and motor output with the excitation by AVP of motor output,
in a way resembling their opposite effects in the CeA.
Facial Motor Nucleus VII and Hypoglossal Nucleus XII
In the neonatal rat, AVP binding sites are highly expressed in
the facial motor nucleus (VII, Figure 5C). Application of AVP
generates a sodium current that is voltage gated, noninactivat-
ing, and TTX resistant. It is possible that AVP exerts this neu-
ronal action by directly activating a receptor-coupled adenylate
cyclase or, alternatively, by activating a PKC through the PLC
pathways that suppresses the activity of a guanine-nucleotide
binding protein which in turn inhibits the AC complex (Raggen-
bass et al., 1991). An intricate interaction between AVP and OT
on local circuits seems to occur in the hypoglossal nucleus,
situated in the myelencephalic part of the brainstem at the
same caudal-rostral level as the dorsal vagal complex and
nucleus ambiguus, though more medially (Figure 5D). Hypo-
glossal (XII) motoneurons innervate both extrinsic and intrin-
sic muscles of the tongue and play an essential role in suckling,
swallowing, breathing, chewing, and vocalization (Wrobel et al.,
2010). XII motoneurons from young rats express V1a receptors
and are strongly activated by AVP. Besides these direct excit-
atory effects, both AVP (through V1a) and OT can also enhance
glycinergic and GABAergic transmission from local interneurons
onto the XII motoneurons (Raggenbass, 2008, Reymond-Marron
et al., 2005; Wrobel et al., 2010). Glycinergic and GABAergic
input in very young animals can be excitatory and this has
been proposed to play a role in the development of motor
neuronal circuits (Singer et al., 1998). In both invertebrates and
vertebrates, complex networks of motoneurons and interneu-
rons can constitute the neuronal substrate underlying rhythmic
motor patterns like breathing, chewing, walking, or swimming.
It is possible that the combined actions of AVP and OT on this
circuitry play an important neuromodulatory role or possibly
even underlie this rhythmicity.
Effects on Central Pattern Generators
In vertebrates, central pattern generators (CPGs) in the spinal
cord are involved in the control of locomotion (Goulding, 2009)
and can be activated and regulated by a variety of neuromodu-
lators (Marder and Bucher, 2001). The proliferation of V1aRs
and OTRs suggests that AVP and OT, by acting on motoneurons
as well as on interneurons or premotor neurons, may function as154 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.such neuromodulators. Indeed, Pearson et al. (2003) demon-
strated that AVP or OT can activate networks of neurons in iso-
lated neonatal mouse spinal cord to generate locomotor-like
activity. Interestingly, a recent study by Wagenaar et al. (2010)
suggests that such a role of AVP and OT can be traced back
far in evolution. Thus, in medicinal leeches (Hirudo), AVP/OT
homologs [Arg8]conopressin, hirudotocin, and annetocin could
exert powerful effects on a CPG located in midbody ganglia
M5 and M6, the ganglia that control the male and female genital
structures. As a result, these compounds elicit twisting behav-
iors and a further complete sequence of behaviors in preparation
of copulation that are normally only induced by exposure to
a specific female pheromone. It thus appears that the effects
of members of the AVP/OT family in the spinal cord may be
associated with a reproductive function of these hormones
throughout the animal kingdom (Wagenaar et al., 2010).
In this context, the OTergic and AVPergic projections from the
hypothalamus, so well preserved over evolution, may play an
important role. The paraventricular nucleus plays a decisive
role in maintaining homeostasis by regulating autonomic func-
tions such as stress response; cardiovascular, breathing, and
renal control; and food intake and body weight regulation. A
direct communication between the paraventricular nucleus and
somatic motor centers could allow rapid integration of auto-
nomic response with motor behavior. For example, an increase
in drive for food intake could correlate with an AVP-mediated
increase in the excitability of motoneurons controlling tongue
and facial muscles, i.e., XII and VII motoneurons. The fact that
V1a receptors are preferentially expressed in motoneurons of
newborn and young animals (Tribollet et al., 1991; Liu et al.,
2003) suggests that this hypothalamic-motor interaction may
be critical early in development in shaping neuronal networks
involved in motor control (Reymond-Marron et al., 2006). Simi-
larly, reproductive behavior requires specific coordinated motor
behavior, such as those underlying lordosis in female rats.
Neuromodulatory roles of OT and AVP may therefore extend
throughout many circuits underlying this behavior, starting
from the sensory triggers to the motor output.
Toward an Integrated View of OT and AVP Effects on
Neural Function
In the above section, a number of neuromodulatory effects by
AVP and OT have been summarized, with their effects on
different nuclei considered as part of a common denominator
in the context of different behavioral systems. In the olfactory
system, OT and AVP seem to exert their effects in concert on
subsequent stations of the pathway, underlining their impor-
tance in the context of social cognition and mating behavior. In
view of their sensitivity to estrogen and progesterone, it seems
important to separate their effects according to gender and
period. In the central amygdala, key structure for raising alert,
and in the sympathetic and parasympathetic system with which
the CeA is connected, OT and AVP exert strikingly opposite
effects. A similar separation into opposite effects seems to oper-
ate in memory and learning and in the spinal cord at the dorsal
sensory input versus the ventral motor output.
For the moment, it remains unclear how the endogenous
supply systems of OT and AVP are handling and coordinating
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Reviewthese modulations. Is there a massive nondistinctive release
on various targets once the OT/VP production and release
machinery has been activated, or is it possible that a more
refined activation at the cellular production level takes place?
Can we distinguish different neuronal populations within the
OT or AVP producing neurons in relation to the behavioral
systems that they innervate? If so, do neuronal populations
that produce OT and AVP coordinate their activities according
to the brain regions and systems that they innervate (and
oppositely regulate)? With the rapid discovery of the precise
promoters and enhancing elements (Gainer, 2012) that regulate
their specific expression, it is becoming possible to specifically
target expression of various protein tools in (part of) these cellular
factories, to dissect in detail these possibly very refined and
specifically targeted regulatory pathways. This may make it
possible, in the future, with a combination of electro-optical
stimulation and pharmacological application, to target more
precisely only parts of the endogenous regulation. The results
of a further detailed understanding of the regulatorymechanisms
may lead to the identification of novel targets for pharmaceutical
developments counteracting a large variety of symptoms linked
to anxiety, memory formation, heart beat, and sexual behavior.ACKNOWLEDGMENTS
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